Custom Product Development Sample Clauses

Custom Product Development. Promptly after the execution of this Agreement, the Parties shall undertake to develop a custom labeled packaged product suitable for marketing with Iomed's Iontophoretic Delivery System and suitable for manufacturing on American Regent Inc.'s standard packaging equipment for fliptop containers. The Parties shall use their reasonable best efforts to successfully complete the product development and to obtain U.S. Food and Drug Administration ("FDA") marketing approval of the Product. It is understood and agreed that 2 there is no guarantee that the product development will be successful and no representation or warranty of any kind is given by either party that a marketable Product will result from the development.
Sample 1Sample 2Sample 3See All (5)
AutoNDA by SimpleDocs
Custom Product Development. 3.1 Mobility agrees to use commercially reasonable efforts to develop any Custom Product (including, without limitation, power or docking station products) requested in writing by Targus, subject to the remainder of this Section. Any Custom Product shall be developed and manufactured pursuant to the terms and conditions of this Agreement (including, without limitation, Section 3.2 below). In addition, prior to commencing the development of any Custom Product, the Parties shall have mutually agreed to a development program schedule, NRE and Tooling Charges, quantity purchase minimum and a PO lead time, which agreement shall be in writing in the form of Attachment 3 to this Agreement. Mobility agrees that it will not market or sell any Custom Product to any person or entity other than Targus.
Sample 1Sample 2
Custom Product Development. 15 3.4 OEM-Loaned Equipment and Related Materials .................16 3.5
Sample 1
Custom Product Development. If OEM requests a custom product development from Adobe (i.e. a product that requires Adobe to develop a version of the Adobe Software that is not then a current product offering of Adobe), Adobe and OEM will negotiate the business terms of this custom development, including, without limitation, the scope of work, technical specification, pricing and milestone schedule, and if the parties can agree, the terms of such agreement will be set forth in a non-standard form of a CPSI Application Appendix to be executed by the parties and made a part of this Agreement. 12/05/96ljm Amiable Technologies Inc. - CPSI OEM AGREEMENT 15
Sample 1
Custom Product Development. Promptly after the execution of this Agreement, the parties shall undertake a project to develop a custom packaged product suitable for marketing with Iomed's iontophoretic medical administration device and suitable for manufacturing on Abbott's xxxxxxxd packaging equipment for fliptop containers. The parties shall use their reasonable best efforts to complete successfully the product development and to obtain U.S. Food and Drug Administration ("FDA") marketing approval of the Product. It is understood and agreed that there is no guarantee that the product development project will be successful and no representation or warranty of any kind is given by either party that a marketable Product will result from the project. 3.
Sample 1

Related to Custom Product Development

  • Product Development SB shall have responsibility for, and control of, the development and commercialization of each Product arising from this Agreement, including process development, delivery system and formulation development, preclinical studies, clinical studies, sales and marketing.

  • Manufacturing Intrexon shall have the option and, in the event it so elects, shall use Diligent Efforts, to perform any manufacturing activities in connection with the Aquaculture Program that relate to the Intrexon Materials, including through the use of a suitable Third Party contract manufacturer. To the extent that Intrexon so elects, Intrexon may request that AquaBounty and Intrexon establish and execute a separate manufacturing and supply agreement, which agreement will establish and govern the production, quality assurance, and regulatory activities associated with manufacture of Intrexon Materials. Except as provided in Section 4.1, any manufacturing undertaken by Intrexon pursuant to the preceding sentence shall be performed in exchange for cash payments equal to Intrexon’s Fully Loaded Cost in connection with such manufacturing, on terms to be negotiated by the Parties in good faith. In the event that Intrexon does not manufacture Intrexon Materials or bulk quantities of other components of AquaBounty Products, then Intrexon shall provide to AquaBounty or a contract manufacturer selected by AquaBounty and approved by Intrexon (such approval not to be unreasonably withheld) all Information Controlled by Intrexon that is (a) related to the manufacturing of such Intrexon Materials or bulk qualities of other components of AquaBounty Products for use in the Field and (b) reasonably necessary to enable AquaBounty or such contract manufacturer (as appropriate) for the sole purpose of manufacturing such Intrexon Materials or bulk quantities of other components of AquaBounty Products. The costs and expenses incurred by Intrexon in carrying out such transfer shall be borne by Intrexon. Any manufacturing Information transferred hereunder to AquaBounty or its contract manufacturer shall not be further transferred to any Third Party, including any Product Sublicensee, or any AquaBounty Affiliate without the prior written consent of Intrexon; provided, however, that Intrexon shall not unreasonably withhold such consent if necessary to permit AquaBounty to switch manufacturers.

  • Product The term “

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Research Neither the Investor nor any Affiliate of the Investor shall have, in the prior thirty (30) days, published or distributed any research report (as such term is defined in Rule 500 of Regulation AC) concerning the Company.

  • Marketing 8.1 Fund or its designee shall periodically furnish Insurance Company with sales literature or other promotional materials for each Portfolio, in quantities as Insurance Company may reasonably request, for distribution to prospective purchasers of Contracts. Expenses for the printing and distribution of such documents shall be borne by Insurance Company.

  • Commercialization Reports After the First Commercial Sale of a Licensed Product anywhere in the Territory, LICENSEE shall submit to Cornell semi-annual reports on or before each February 28 and August 31 of each year. Each report shall cover LICENSEE’s (and each Affiliate’s and Sublicensee’s) most recently completed calendar half-year and shall show:

  • Development Work Do, or cause to be done, such development and other work as may be reasonably necessary to protect from diminution and production capacity of the Mortgaged Property and each producing well thereon.

  • Development of Products (a) During the term of this Agreement, ViewRay may from time to time seek services from PEKO with respect to the development of certain Products that can be incorporated into the ViewRay Renaissance™ MRI-guided radiation therapy system. For each Program to be undertaken by PEKO pursuant to this Agreement, the parties will prepare a “Work Statement” and agree to said “Work Statement” in substantially the form attached as Attachment 1. Each Work Statement will describe: (i) the (i) services that PEKO will be responsible for providing to ViewRay and the deliverables that PEKO will be responsible for delivering to ViewRay (“Deliverable(s)”), (ii) delivery schedule for the Deliverables, (iii) pricing terms, (iv) work plan for the Program, and (v) ViewRay’s responsibilities in connection with the Program. Each Work Statement will be prepared based upon the requirements and information provided to PEKO by ViewRay. A separate Work Statement will be required for each Program; and each Work Statement will become subject to this Agreement only when mutually agreed and signed by ViewRay and PEKO.

  • Development 3.1.1 Licensee agrees to and warrants that:

Time is Money Join Law Insider Premium to draft better contracts faster.